12 results
424B3
PROK
ProKidney Corp - Ordinary Shares
21 Apr 23
Prospectus supplement
4:18pm
congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing … price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures
POS AM
PROK
ProKidney Corp - Ordinary Shares
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform … access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk
424B3
PROK
ProKidney Corp - Ordinary Shares
9 Sep 22
Prospectus supplement
5:05pm
things, bring more transparency to medicines pricing, reduce the cost of prescription medicines under government payor programs and review the relationship … or specific intent to violate it in order to have committed a violation;
the federal transparency requirements under the ACA, including the provision
DEFM14A
m0h4njcf131r
10 Jun 22
Proxy related to merger
4:54pm
PRER14A
72419t ffncs
11 Apr 22
Preliminary revised proxy
5:29pm
PREM14A
c6dnuhxtv
14 Feb 22
Preliminary proxy related to merger
4:55pm
DEFA14A
z7x 4lz4ab
18 Jan 22
Additional proxy soliciting materials
5:15pm
- Prev
- 1
- Next